About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin focused on the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges such as mild memory problems associated with aging.
Quincy Bioscience is set apart by its use of apoaequorin, a protein originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility.
The discovery and development of Apoaequorin in 1962 as a calcium signaler earned the scientists responsible the Nobel Prize in Chemistry in 2008. Quincy Bioscience is building on this work through its novel use of the protein.Apoaequorin achieved self-affirmed GRAS status (generally recognized as safe) after an independent panel of expert scientists concluded that apoaequorin is safe for use in food products.
Prevagen® is the company’s flagship consumer brand containing apoaequorin which has shown in published studies to be safe and effective. A landmark double-blind and placebo-controlled trial demonstrated Prevagen improved short-term memory, learning, and delayed recall over 90 days.
As a result of the supplement’s safety and effectiveness, Prevagen is now the number one selling brain support supplement in chain pharmacies across America according to A.C. Nielsen data (April, 2014).
In 2012, the first year of eligibility, Quincy Bioscience ranked #398 on the Inc. 500 list of fastest growing private companies in the United States.
Quincy Bioscience manufactures Prevagen and Prevagen Professional in the state of Wisconsin following NNFA Good Manufacturing Practices (GMP) guidelines using sophisticated fermentation technology.